BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15764347)

  • 1. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):13-27. PubMed ID: 15764348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
    Hauck ML; Dewhirst MW; Bigner DD; Zalutsky MR
    Clin Cancer Res; 1997 Jan; 3(1):63-70. PubMed ID: 9815539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
    Hauck ML; Zalutsky MR
    Clin Cancer Res; 1998 Sep; 4(9):2071-7. PubMed ID: 9748121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.
    Cope DA; Dewhirst MW; Friedman HS; Bigner DD; Zalutsky MR
    Cancer Res; 1990 Mar; 50(6):1803-9. PubMed ID: 2407344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
    De Santis R; Albertoni C; Petronzelli F; Campo S; D'Alessio V; Rosi A; Anastasi AM; Lindstedt R; Caroni N; Arseni B; Chiodi P; Verdoliva A; Cassani G; Chinol M; Paganelli G; Carminati P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2191-6. PubMed ID: 16609034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB; Langmuir VK; Mendonca HL; Goris ML; Knox SJ
    Cancer Res; 1993 Jul; 53(13):3022-7. PubMed ID: 8319209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
    Gold DV; Goldenberg DM; Karacay H; Rossi EA; Chang CH; Cardillo TM; McBride WJ; Sharkey RM
    Cancer Res; 2008 Jun; 68(12):4819-26. PubMed ID: 18559529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent.
    Reist CJ; Bigner DD; Zalutsky MR
    Clin Cancer Res; 1998 Oct; 4(10):2495-502. PubMed ID: 9796983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues.
    Schuster JM; Zalutsky MR; Noska MA; Dodge R; Friedman HS; Bigner DD; Dewhirst MW
    Int J Hyperthermia; 1995; 11(1):59-72. PubMed ID: 7714371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
    Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
    Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure.
    Hauck ML; Coffin DO; Dodge RK; Dewhirst MW; Mitchell JB; Zalutsky MR
    Int J Hyperthermia; 1997; 13(3):307-16. PubMed ID: 9222813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.